Beirne Wealth Consulting Services’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
S
TCMG
OAM
SO
AA
PAG
PFSRSONJ
YIH
Beirne Wealth Consulting Services's NVAX Position: Q2 2026 in Review
Beirne Wealth Consulting Services held its Novavax (NVAX) position steady in Q2 2026 at 15,000 shares worth $141K. The position accounts for 0.03% of the portfolio, ranked #101.
Beirne Wealth Consulting Services first reported a position in NVAX in Q4 2018 and has held it in 18 quarters since. The position peaked at $1.85M in Q2 2020. 64 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.
- Beirne Wealth Consulting Services held 15,000 shares of Novavax worth $141K as of Q2 2026.
- Beirne Wealth Consulting Services left its Novavax share count unchanged in Q2 2026.
- Novavax made up 0.03% of Beirne Wealth Consulting Services's portfolio in Q2 2026, its #101 holding.
- Beirne Wealth Consulting Services first reported a position in Novavax in Q4 2018 and has held it in 18 quarters since.
- Beirne Wealth Consulting Services's Novavax position peaked at $1.85M in Q2 2020.
- 64 funds tracked by Wall St. Rank held Novavax as of Q2 2026.
Based on Beirne Wealth Consulting Services's 13F filing for Q2 2026, filed 15 Jul 2026.